STD 07

Drug Profile

STD 07

Alternative Names: STD-007; STD07

Latest Information Update: 16 Sep 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator SunTen Phytotech
  • Developer Lumosa Therapeutics
  • Class Anthraquinones
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes - Gastrointestinal disorders

Highest Development Phases

  • Discontinued Constipation; Inflammatory bowel diseases

Most Recent Events

  • 16 Sep 2015 Discontinued - Phase-I for Inflammatory bowel disease in Taiwan (PO)
  • 16 Sep 2015 Discontinued - Phase-I/II for Constipation in Taiwan (PO)
  • 11 Feb 2011 Phase I/II development is ongoing in Taiwan
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top